Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Blood Pressure Monitoring|February 4, 2010
Validation of two blood pressure measurement devices according to the European Society of Hypertension International Protocol: the citizen CH-463E and the citizen CH-461CHannah Broelmann, Joseph C Sprenger, Verena H Faltenbacher, et al.Oncogene|April 13, 2004
Suppression of growth and tumorigenicity in the prostate tumor cell line M12 by overexpression of the transcription factor SOX9Rolf Drivdahl, Kathy H Haugk, Cynthia C Sprenger, et al.Endocrinology|January 6, 2001
Transcriptional regulation of insulin-like growth factor-I receptor gene expression in prostate cancer cellsS E Damon, S R Plymate, J M Carroll, et al.The Prostate|May 15, 2003
Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1/mac 25) is reduced in human prostate cancer and is inversely related to tumor volume and proliferation index in Lucap 23.12 xenograftsMarie K Tennant, Robert L Vessella, Cynthia C Sprenger, et al.Journal of Water and Health|June 18, 2014
Removal of indigenous coliphages and enteric viruses during riverbank filtration from highly polluted river water in Delhi (India)C Sprenger, G Lorenzen, A Grunert, et al.Oncogene|February 20, 2003
Increased manganese superoxide dismutase (SOD-2) is part of the mechanism for prostate tumor suppression by Mac25/insulin-like growth factor binding-protein-related protein-1Stephen R Plymate, Kathy H Haugk, Cynthia C Sprenger, et al.Herzschrittmachertherapie & Elektrophysiologie|August 3, 2010
[Registry and studies of the German Competence Network on Atrial Fibrillation (AFNET)]M Nabauer, A Gerth, P Kirchhof, et al.Molecular Cancer Therapeutics|February 15, 2020
Antitumor Activity of the IGF-1/IGF-2-Neutralizing Antibody Xentuzumab (BI 836845) in Combination with Enzalutamide in Prostate Cancer ModelsUlrike Weyer-Czernilofsky, Marco H Hofmann, Katrin Friedbichler, et al.The Journal of Clinical Endocrinology and Metabolism|March 28, 2013
Response of the insulin-like growth factor (IGF) system to IGF-IR inhibition and androgen deprivation in a neoadjuvant prostate cancer trial: effects of obesity and androgen deprivationJames P Dean, Cynthia C Sprenger, Junxiang Wan, et al.Biorxiv : the Preprint Server for Biology|July 18, 2023
A Compound that Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate CancerTakuma Uo, Kayode K Ojo, Cynthia C Sprenger, et al.Pageof 3